Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics Inc
(NQ:
STOK
)
11.43
+0.16 (+1.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
243,374
Open
11.32
Bid (Size)
10.00 (25)
Ask (Size)
13.08 (1)
Prev. Close
11.27
Today's Range
11.15 - 11.60
52wk Range
3.770 - 17.58
Shares Outstanding
44,188,534
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
November 05, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome
September 10, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+95.05%
+95.05%
1 Month
-5.22%
-5.22%
3 Month
-18.30%
-18.30%
6 Month
-20.68%
-20.68%
1 Year
+184.33%
+184.33%
More News
Read More
A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics
June 28, 2024
Via
Benzinga
Analyst Expectations For Stoke Therapeutics's Future
May 06, 2024
Via
Benzinga
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
April 04, 2024
Via
Benzinga
Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
September 04, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at Upcoming Investor Conferences in September
September 03, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for Zorevunersen to be the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome
September 03, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 16, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
August 07, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 16, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
June 24, 2024
Via
Benzinga
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 18, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
June 03, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 17, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
Via
InvestorPlace
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 06, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
April 29, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
April 17, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
March 27, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
What's Going On With Stoke Therapeutics Stock Tuesday?
March 26, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.